Oxidative and Osmotic Stress Signaling in Tumor Cells Is Mediated by ADAM Proteases and Heparin-Binding Epidermal Growth Factor
暂无分享,去创建一个
[1] S. Y. Cajal,et al. Role of the p38 MAPK pathway in cisplatin-based therapy , 2003, Oncogene.
[2] David C. Lee,et al. Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.
[3] E. Wagner,et al. c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. , 2003, Developmental cell.
[4] R. Derynck,et al. Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-α Converting Enzyme and of an Alternatively Translated Polypeptide* , 2003, The Journal of Biological Chemistry.
[5] Stefan Hart,et al. TACE cleavage of proamphiregulin regulates GPCR‐induced proliferation and motility of cancer cells , 2003, The EMBO journal.
[6] E. Mekada,et al. The Stress- and Inflammatory Cytokine-induced Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor Is Mediated by p38 MAPK, Distinct from the 12-O-Tetradecanoylphorbol-13-acetate- and Lysophosphatidic Acid-induced Signaling Cascades* , 2003, The Journal of Biological Chemistry.
[7] C. Estrada,et al. Nitric oxide-induced epidermal growth factor-dependent phosphorylations in A431 tumour cells. , 2003, European journal of biochemistry.
[8] J. Baselga,et al. TACE is required for the activation of the EGFR by TGF‐α in tumors , 2003 .
[9] M. Mifune,et al. Distinct Mechanisms of Receptor and Nonreceptor Tyrosine Kinase Activation by Reactive Oxygen Species in Vascular Smooth Muscle Cells: Role of Metalloprotease and Protein Kinase C-δ , 2003, Molecular and Cellular Biology.
[10] G. Johnson,et al. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.
[11] A. Ullrich,et al. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. , 2002, Cancer research.
[12] Joseph Schlessinger,et al. Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor , 2002, Cell.
[13] Eulàlia de Nadal,et al. Dealing with osmostress through MAP kinase activation , 2002, EMBO reports.
[14] J. Kartenbeck,et al. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol , 2002, Journal of cellular physiology.
[15] Z. Werb,et al. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein–coupled receptors , 2002, The Journal of cell biology.
[16] E. Dı́az-Rodrı́guez,et al. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. , 2002, Molecular biology of the cell.
[17] A. Levitzki,et al. ROS, stress‐activated kinases and stress signaling in cancer , 2002, EMBO reports.
[18] David C. Lee,et al. Tumor Necrosis Factor-α Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand Availability* , 2002, The Journal of Biological Chemistry.
[19] G. Weskamp,et al. Mice Lacking the Metalloprotease-Disintegrin MDC9 (ADAM9) Have No Evident Major Abnormalities during Development or Adult Life , 2002, Molecular and Cellular Biology.
[20] J. den Hertog,et al. Regulation of receptor protein‐tyrosine phosphatase α by oxidative stress , 2002 .
[21] R. Peek,et al. cag+ Helicobacter pylori Induce Transactivation of the Epidermal Growth Factor Receptor in AGS Gastric Epithelial Cells* , 2001, The Journal of Biological Chemistry.
[22] J. Baselga,et al. Metalloprotease-dependent Protransforming Growth Factor-α Ectodomain Shedding in the Absence of Tumor Necrosis Factor-α-converting Enzyme* , 2001, The Journal of Biological Chemistry.
[23] E. Mekada,et al. A Dual Signaling Cascade That Regulates the Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor* , 2001, The Journal of Biological Chemistry.
[24] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[25] Kai Chen,et al. c-Jun N-terminal Kinase Activation by Hydrogen Peroxide in Endothelial Cells Involves Src-dependent Epidermal Growth Factor Receptor Transactivation* , 2001, The Journal of Biological Chemistry.
[26] J. Avruch,et al. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.
[27] U. Rodeck,et al. Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[28] A. Ullrich,et al. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. , 2001, Endocrine-related cancer.
[29] N. Holbrook,et al. Oxidants, oxidative stress and the biology of ageing , 2000, Nature.
[30] Y. Taya,et al. A Role for the p38 Mitogen-activated Protein Kinase Pathway in the Transcriptional Activation of p53 on Genotoxic Stress by Chemotherapeutic Agents , 2000 .
[31] R. Derynck,et al. Ectodomain shedding of TGF‐α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades , 1999, The EMBO journal.
[32] D. Ingber,et al. The Shedding of Membrane-anchored Heparin-binding Epidermal-like Growth Factor Is Regulated by the Raf/Mitogen-activated Protein Kinase Cascade and by Cell Adhesion and Spreading* , 1999, The Journal of Biological Chemistry.
[33] G. Carpenter. Employment of the Epidermal Growth Factor Receptor in Growth Factor–Independent Signaling Pathways , 1999, The Journal of cell biology.
[34] O. Rotstein,et al. Cell Volume-dependent Regulation of L-selectin Shedding in Neutrophils , 1999, The Journal of Biological Chemistry.
[35] M. Maa,et al. c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.
[36] S. Parsons,et al. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] E. Mekada,et al. A metalloprotease–disintegrin, MDC9/meltrin‐γ/ADAM9 and PKCδ are involved in TPA‐induced ectodomain shedding of membrane‐anchored heparin‐binding EGF‐like growth factor , 1998, The EMBO journal.
[38] David C. Lee,et al. An essential role for ectodomain shedding in mammalian development. , 1998, Science.
[39] T. Finkel. Oxygen radicals and signaling. , 1998, Current opinion in cell biology.
[40] A. Ullrich,et al. Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.
[41] Kohjiro Ueki,et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone , 1997, Nature.
[42] Michael Karin,et al. Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.
[43] A. Ullrich,et al. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. , 1996, The EMBO journal.
[44] G. Rao. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. , 1996, Oncogene.
[45] A. Ullrich,et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.
[46] R. Burdon. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. , 1995, Free radical biology & medicine.
[47] C. Nathan,et al. Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.
[48] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[49] J. Baselga,et al. TACE is required for the activation of the EGFR by TGF-alpha in tumors. , 2003, The EMBO journal.
[50] Hiroshi Asanuma,et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy , 2002, Nature Medicine.
[51] C. Basbaum,et al. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells , 2002, Nature Medicine.
[52] J. den Hertog,et al. Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress. , 2002, The EMBO journal.
[53] Y. Matsuzawa,et al. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells. , 2001, Gastroenterology.
[54] J. Baselga,et al. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. , 2001, The Journal of biological chemistry.
[55] M. Cobb,et al. MAP kinases. , 2001, Chemical reviews.
[56] M. Karin,et al. Assays for JNK and p38 mitogen-activated protein kinases. , 2000, Methods in enzymology.
[57] A. Ullrich,et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.
[58] H. Kamata,et al. Redox regulation of cellular signalling. , 1999, Cellular signalling.
[59] J. Schlessinger,et al. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock. , 1989, Oncogene.